Texas CPRIT Clinical Trials Network Award — FY 2027 Cycle 2

CPRIT will accept FY 2027 Cycle 2 applications beginning September 16, 2026 for awards up to $2.5 million over five years to build networks that extend phase 2 and phase 3 cancer clinical trials to Texas cancer-care facilities that currently lack access.

FundingUp to $2,500,000 over a 5-year period

DeadlineApplication receipt opens September 16, 2026 and closes November 18, 2026; award notification is expected May 2027

Last verifiedAugust 29, 2026

Required next actionReview the FY 2027 Cycle 2 Clinical Trials Network RFA and CPRIT GMP instructions, confirm the lead institution, organization or physician group has established clinical-trials infrastructure and a qualifying trial portfolio, identify network affiliates that currently lack trial access, define the common IRB and clinical-trial management model, and prepare the GMP application for the September 16 through November 18, 2026 receipt window.

Broad Eligibility

CPRIT describes the opportunity as supporting an institution, organization or physician group with established clinical-trials infrastructure and a clinical-trials portfolio to develop and oversee a network of cancer-care facilities that currently lack access to clinical trials. The lead must meet the controlling CPRIT Academic Research RFA and FY 2027 Cycle 2 requirements; applicants should confirm all institutional, investigator and Texas eligibility criteria in the final RFA and GMP instructions before submission.

Atlas Analysis

Exceptional Texas cancer-care access opportunity because it funds the infrastructure needed to extend phase 2 and phase 3 oncology trials beyond established research centers. Strong candidates should bring a credible lead trial program, affiliates with documented access gaps, a common IRB strategy, shared clinical-trial management capability, recruitment and retention plans, and measurable geographic expansion of trial access across Texas.

Source verificationOfficial government source · www.cprit.texas.govAtlas last verified this record August 29, 2026. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗